Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −18,415−100.0% | Sold out | Holders |
| Q4 2024 | 18,415 | $405.9K | <0.1% | −93,117−83.5% | Reduced | Holders |
| Q3 2024 | 111,532 | $2.01M | <0.1% | +55,252+98.2% | Added | Holders |
| Q2 2024 | 56,280 | $914.5K | <0.1% | +27,224+93.7% | Added | Holders |
| Q1 2024 | 29,056 | $410.0K | <0.1% | −191,202−86.8% | Reduced | Holders |
| Q4 2023 | 220,258 | $586.9K | <0.1% | +220,258 | New | Holders |